KBRA Releases U.S. Bank 1Q22 Compendium
05/12/2022 - 06:05 PM
NEW YORK --(BUSINESS WIRE)--
KBRA releases its First-Quarter 2022 U.S. Bank Compendium. The Compendium provides our latest view of the U.S. banking sector and analyzes the 1Q22 results of U.S. banks with KBRA long-term ratings. This edition includes a spotlight on the pronounced inflationary pressure on vehicle prices, as well as auto loan exposures among the KBRA-rated bank population. In addition, the Compendium includes our quarterly environmental, social, and governance (ESG) Bulletin, which features PacWest Bancorp
The Compendium includes 1Q22 summaries on all publicly traded U.S. banks in KBRA’s rated universe, focusing on key performance and credit metrics, along with medians of key ratios. The Compendium also includes the top 10 lowest cost deposit franchises, highest reserves to loans, and largest sequential changes in return on assets, net interest margin, net charge-offs, and nonperforming asset ratios. In addition, we provide a supplement with 171 debt issues—along with rating, amount issued, coupon, and maturity—among KBRA-rated banks.
Click here to view the report.
Related Publications
About KBRA
KBRA is a full-service credit rating agency registered in the U.S. , the EU and the UK , and is designated to provide structured finance ratings in Canada . KBRA’s ratings can be used by investors for regulatory capital purposes in multiple jurisdictions.
View source version on businesswire.com : https://www.businesswire.com/news/home/20220512006107/en/
Leah Hallfors , Senior Director
leah.hallfors@kbra.com
John Rempe , Director
john.rempe@kbra.com
Brian Ropp , Managing Director
brian.ropp@kbra.com
Bryan So, Director
bryan.so@kbra.com
Shannon Servaes , CFA, CPA Managing Director
shannon.servaes@kbra.com
Ian Jaffe , Managing Director
ian.jaffe@kbra.com
Joe Scott , Senior Managing Director
joe.scott@kbra.com
B usiness Development Contact
Constantine Schidlovsky , Senior Director
constantine.schidlovsky@kbra.com
Source: Kroll Bond Rating Agency
Bausch Health Companies Inc
BHC Rankings
#1934 Ranked by Stock Gains
BHC Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Other, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
CA
City
Laval
About BHC
bausch health companies inc. (nyse/tsx: bhc) is a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. we are delivering on our commitments as we build an innovative company dedicated to advancing global health. our approximately 22,000 employees are united around our mission of improving people’s lives with our health care products, and we manufacture and market health care products directly or indirectly in approximately 100 countries.five pillars, or guiding principles, represent the foundation on which we are realizing our mission as an organization: people, quality health care outcomes, customer focus, innovation and efficiency. more information can be found at www.bauschhealth.com.###
